Pacific Biosciences Of California (PACB) Inventory (2010 - 2026)

Pacific Biosciences Of California has reported Inventory for 17 years, with the latest figure at $61.1 million in Q2 2026.

• On a quarterly basis, Inventory rose 13.46% year-over-year to $61.1 million in Q2 2026; TTM through Jun 2026 was $61.1 million, a 13.46% increase from a year earlier, with the FY2025 full-year figure at $49.3 million, down 16.12% from the prior year.
• Inventory was $61.1 million for Q2 2026 at Pacific Biosciences Of California, up from $51.0 million in the prior quarter.
• The five-year high for Inventory was $68.6 million in Q2 2024, with the low at $29.6 million in Q1 2022.
• Average Inventory over 5 years is $55.4 million, with a median of $55.3 million recorded in 2023.
• The sharpest annual moves came in 2023 and 2025: Inventory jumped 109.13% in 2023, then fell 21.51% in 2025.
• Over 5 years, Inventory stood at $50.4 million in 2022, then grew by 12.49% to $56.7 million in 2023, then grew by 3.67% to $58.8 million in 2024, then slipped by 16.12% to $49.3 million in 2025, then rose by 23.94% to $61.1 million in 2026.
• The last three Inventory figures came in at $61.1 million (Q2 2026), $51.0 million (Q1 2026), and $49.3 million (Q4 2025), per Business Quant data.